Astrazeneca plc

AZNNYSE · USD
178.76USD0.00 (-1.93%)
689

Astrazeneca plc (AZN) Historical Volatility

AZN's 30 day historical volatility is 31.74%, in the 69th percentile of readings over the past year. This is an average percentile, meaning Astrazeneca plc shares have moved roughly in line with their typical range. AZN's 30 day implied volatility sits at 26.53%, with an IV Rank of 19.84%, leaving IV 5.21 points below historical volatility. This means options are pricing in less movement than the stock has actually delivered, as of Nov 18, 2026.

Read more

Tracking AZN historical volatility helps you see how much Astrazeneca plc's stock price has actually moved, giving you a baseline for whether option premiums look fair, cheap, or expensive. While implied volatility shows what the market expects, AZN's HV, also known as realized volatility, shows what actually happened. Use our scanner to monitor AZN 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of a stock's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. AZN's 30 day historical volatility, or AZN HV, is one of the most widely watched readings because it balances responsiveness with stability. Comparing AZN's HV to its implied volatility reveals the volatility risk premium. When IV sits well above HV, options are pricing in more movement than the stock has actually delivered, giving option sellers an edge. When HV runs hot relative to IV, options are pricing in less movement than the stock has delivered, and buyers may be underpaying for it.

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease.

Historical Volatility

HV Percentile
69thHV Percentile
Moderate

Historical movement is near its typical level for the past year. Neither unusually calm nor unusually active.

Historical Volatility (30d)31.74%

HV Percentile69th

Implied Volatility (30d)26.53%

IV Rank19.84%

IV Minus HV-5.21%

As of Nov 18, 2026

IV vs HV
Implied Volatility (IV) vs Historical Volatility (HV) over the past month.

As of Nov 18, 2026

IV - HV Difference
Difference between IV and HV over time. Positive values indicate IV > HV.

As of Nov 18, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →